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Revisiting the association of blood pressure with mortality in  
oldest old people in China: community based, longitudinal  
prospective study
Yue-Bin Lv,1 Xiang Gao,2 Zhao-Xue Yin,3 Hua-Shuai Chen,4 Jie-Si Luo,3 Melanie Sereny Brasher,5 
Virginia Byers Kraus,6 Tian-Tian Li,1 Yi Zeng,4 7 Xiao-Ming Shi1
ABSTRACT
OBJECTIVE
To examine the associations of blood pressure with all 
cause mortality and cause specific mortality at three 
years among oldest old people in China.
DESIGN
Community based, longitudinal prospective study.
SETTING
2011 and 2014 waves of the Chinese Longitudinal 
Healthy Longevity Survey, conducted in 22 Chinese 
provinces.
PARTICIPANTS
4658 oldest old individuals (mean age 92.1 years).
MAIN OUTCOME MEASURES
All cause mortality and cause specific mortality 
assessed at three year follow-up.
RESULTS
1997 deaths were recorded at three year follow-up. U 
shaped associations of mortality with systolic blood 
pressure, mean arterial pressure, and pulse pressure 
were identified; values of 143.5 mm Hg, 101 mm Hg, 
and 66 mm Hg conferred the minimum mortality risk, 
respectively. After adjustment for covariates, the U 
shaped association remained only for systolic blood 
pressure (minimum mortality risk at 129 mm Hg). 
Compared with a systolic blood pressure value of 129 
mm Hg, risk of all cause mortality decreased for values 
lower than 107 mm Hg (from 1.47 (95% confidence 
interval 1.01 to 2.17) to 1.08 (1.01 to 1.17)), and 
increased for values greater than 154 mm Hg (from 
1.08 (1.01 to 1.17) to 1.27 (1.02 to 1.58)). In the 
cause specific analysis, compared with a middle range 
of systolic blood pressure (107-154 mm Hg), higher 
values (>154 mm Hg) were associated with a higher 
risk of cardiovascular mortality (adjusted hazard 
ratio 1.51 (95% confidence interval 1.12 to 2.02)); 
lower values (<107 mm Hg) were associated with a 
higher risk of non-cardiovascular mortality (1.58 (1.26 
to 1.98)). The U shaped associations remained in 
sensitivity and subgroup analyses.
CONCLUSIONS
This study indicates a U shaped association between 
systolic blood pressure and all cause mortality at 
three years among oldest old people in China. This 
association could be explained by the finding that 
higher systolic blood pressure predicted a higher 
risk of death from cardiovascular disease, and that 
lower systolic blood pressure predicted a higher 
risk of death from non-cardiovascular causes. These 
results emphasise the importance of revisiting 
blood pressure management or establishing specific 
guidelines for management among oldest old 
individuals.
Introduction
Hypertension and hypotension are well established 
risk factors of morbidity and survival before the age 
of 80 years1 2; however, the contribution of those 
conditions to all cause mortality weakens with ageing. 
Whether this attenuation is a natural ageing process 
or a pathological process that should to be intervened 
remains unclear. The number of oldest old people 
(aged ≥80 years) will be the fastest growing group 
between now and 2050; therefore, it is important to 
determine whether a significant association exists 
between blood pressure and all cause mortality or 
cause specific mortality in this age group. However, 
conflicting results have been reported—especially 
regarding systolic blood pressure and diastolic blood 
pressure. Most observational studies have found 
that changes in systolic or diastolic blood pressure 
predicted higher mortality risk,3-11 even showing a 
J or U shaped association12-14; however, some have 
failed to detect significant association between blood 
pressure and mortality.15 16 One meta-analysis showed 
that higher systolic blood pressure predicted increased 
mortality risk in all age groups, including oldest old 
people.17 Furthermore, some experimental studies 
have found that the treatment of isolated systolic 
hypertension prevented stroke and heart failure; 
but findings regarding prevention against all cause 
mortality have been conflicting for people aged over 
80 years.18-21
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WhAT IS AlReAdy knoWn on ThIS TopIC
Hypertension and hypotension are well established risk factors of morbidity and 
survival in middle aged or younger elderly people, while the association weakens 
with age
For people aged 80 years and older, previous studies regarding the role of blood 
pressure in all cause mortality and cause specific mortality have generated 
conflicting results
WhAT ThIS STudy AddS
Among a study sample group of oldest old people in China, systolic blood 
pressure showed a U shaped association with three year all cause mortality
Higher values of systolic blood pressure predicted a higher risk of cardiovascular 
mortality, and lower values predicted a higher risk of non-cardiovascular 
mortality
The present paradigm of “the lower the better” in blood pressure regulation does 
not apply to oldest old people, and optimal blood pressure might need revisiting 
after age 80 years 
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The following limitations with previous studies need 
to be addressed:3-21
•   The number  of  oldest  old  participants was  limited 
(<1000) in most studies. Most participants 
were octogenarians and nonagenarians, with 
centenarians under-represented.
•   Most studies focused on specific populations or high 
risk populations (eg, patients with hypertension); 
studies on community based populations were 
lacking. 
•   No linear or curvilinear associations were examined 
by Cox models with penalised splines,22 which is a 
valid approach for determining the shapes of the 
association. 
•   No  previous  studies  focused  on  the  role  of  mean 
arterial pressure; very few studies investigated pulse 
pressure,7 which may be more salient blood pressure 
indexes for mortality in this age group.23 24
•   Most  studies  were  implemented  in  developed 
countries  (Finland,  Japan,  Netherlands,  Spain, 
Sweden, United States), while research in developing 
countries is very limited regarding the potential role 
of blood pressure in mortality among this age group.
In the present community based study, we aimed to 
deal with some of these existing gaps, by examining 
the role of blood pressure in all cause mortality or 
cause specific mortality among 4658 oldest old people 
during a three year follow-up. We used Cox models 
with penalised splines in our primary analyses and 
accounted for several important confounding factors, 
including clinical diseases, frailty, and functional 
impairment.
Methods
Study cohort
Participants were recruited from the sixth wave (2011) 
Chinese  Longitudinal  Healthy  Longevity  Survey 
(CLHLS). A multistage cluster sampling approach was 
used in this prospective, longitudinal, community 
based study. We initially selected 22 provinces of 
China (Beijing, Tianjin, Chongqing, Shanghai, Anhui, 
Fujian, Guangdong, Guangxi, Hubei, Hunan, Henan, 
Hebei, Heilongjiang, Liaoning, Jiangxi, Jiangsu, Jilin, 
Shandong, Shaanxi, Shanxi, Sichuan, and Zhejiang); 
we then randomly selected half the cities or counties 
in these provinces. 
All  centenarians  were  interviewed  in  the  801 
randomly  selected  cities  or  counties.  Nearby 
individuals (eg, in the selected street or village, or 
in the selected city or county) were invited to be 
investigated to match with each centenarian. These 
matched individuals included younger elderly people 
(aged 65-79 years), octogenarians, and nonagenarians 
of predefined sex and age. The predefined sex and age 
were in accordance with the centenarians’ randomly 
assigned code numbers. This process ensured that the 
numbers of randomly selected men and women were 
comparable in the three age groups (65-79, 80-89, 90-
99  years).  A more  detailed  description  of  the  CLHLS 
has been published elsewhere.25 Based on systematic 
assessments of the randomness of attrition, credibility 
and validity of the measurement scale, and accuracy 
of reported age, the quality of the data for this study 
was high.25 26
In all, 7328 elderly individuals were initially 
included  in  the  2011  CLHLS.  We  excluded  2670 
participants because they were younger elderly (≤79 
years; n=2437), had incorrect death dates (n=43), or 
were lacking blood pressure values (n=190). Finally, 
4658 oldest old participants met the inclusion criteria 
(2001 octogenarians, 1832 nonagenarians, and 825 
centenarians;  fig  S1).  A  structured  questionnaire 
was used by a trained staff member from the county 
Centers for Disease Control and Prevention to conduct 
interviews. The information was collected from proxy 
respondents, usually close family member or spouse, if 
participants were unable to answer questions.
During the three year study period, 247 (5.3%) 
participants  were  lost  to  follow-up  (fig  S1).  The 
participants’ survival status and date of death were 
collected during the follow-up survey in 2014. 
Information about death was ascertained and affirmed 
by the close family member or village doctor of the 
participant. Participants who could not be found or 
contacted were designated as lost to follow-up.27  A 
supplementary phone interview was conducted to 
obtain information about antihypertensive treatment 
in participants who self reported hypertension and 
about cause specific mortality (cardiovascular v 
non-cardiovascular) mortality in decedents. We used 
ICD-10 (international classification of diseases, 10th 
revision) to assess participants’ underlying cause of 
death from cardiovascular disease (codes I00-I78) 
or ischaemic heart disease (I20-I25). In all, 339 
(28.4%) of 1195 patients with hypertension were 
successfully followed up; details of cause of death 
for 1088 (54.5%) participants were successfully 
obtained.  A  statistical  analysis  of  cardiovascular 
and non-cardiovascular mortality is in the online 
supplemental material.
Measurement and calculation of blood pressure
After  participants  had  rested  for  at  least  five 
minutes, research assistants took two measurements 
of blood pressure on the right arm by mercury 
sphygmomanometer (upper arm type; Yuyue, Jiangsu, 
China). Korotkoff phase I was designated for the 
systolic blood pressure values, phase V for the diastolic 
blood pressure values. For bedbound participants, 
blood pressure measurements were obtained in a 
recumbent position. For further analyses, the mean 
value was calculated with the two measurements 
(pulse pressure=systolic blood pressure−diastolic 
blood pressure; mean arterial pressure=(systolic blood 
pressure+(2×diastolic blood pressure))÷3.
Assessment of covariates
Covariates were obtained by use of a structured 
questionnaire. One section included sociodemographic 
characteristics, comprising details of age, sex, 
educational background, residence, marital status, 
and economic income. The other section dealt with 
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health characteristics; it covered smoking, drinking, 
activities of daily living, visual function, cognition, 
body mass index, waist circumference, and self 
reported diseases diagnosed by a doctor—for instance, 
diabetes mellitus, stroke and other cerebrovascular 
diseases, cardiovascular disease, respiratory disease, 
and cancer.
Residence was categorised as urban (city residence) 
or rural (town or countryside residence). Marital status 
was categorised as “not in marriage” if a participant 
had never married or was widowed or divorced and 
“in marriage” if a participant was currently married. 
Economic income was classified as “high” and 
“medium or low” by the question “Compared with 
other locals, how do you think about your economic 
position?” Current smoking practice and alcohol 
consumption habits were assessed by self report based 
on the questions “Do you currently smoke?” and “Do 
you currently drink alcohol?” 
Visual function was classified as “good” or “poor” 
according to whether participants were able to 
identify the break in the image of a circle held before 
them.  A  non-stretchable  tape  was  used  to measure 
waist circumference with the participant lightly 
clothed; measurement was made between the iliac 
crest and the lowest rib. Central obesity was defined 
as a waist circumference at least 80 cm for women 
and at least 85 cm for men. Body mass index was 
calculated as bodyweight (kg) divided by squared 
body height (m2). We defined cognitive impairment 
as a mini-mental status examination score lower 
than 24. Restriction in activities of daily living 
was defined as a participant being dependent in 
toileting, bathing, indoor activities, dressing, eating, 
or continence. We defined comorbidity as 0 or at 
least 1 according to the number of diseases (stroke 
and other cerebrovascular diseases, cardiovascular 
disease, diabetes mellitus, respiratory disease, and 
cancer) that the participant had. 
Frailty was defined by the study of osteoporotic 
fractures index.28 The index included three 
components: underweight (body mass index<18.5); 
participants having trouble standing up from a chair 
without the assistance of arms; and a positive response 
to the question “Over the last 6 months, have you been 
limited in activities because of a health problem?,” 
indicating reduced energy level. We categorised frailty 
in three states: frail (two or three components); pre-
frail (one component); and robust (no components), 
which showed good ability for biological age among 
Chinese elderly people.29 Overall, few data for the 
covariates were missing (<3%): fewer than 1% of the 
data were missing for any single variable, and we did 
multiple imputation methods for the correction of 
missing data in covariates.30 31
Statistical analysis
We used the Kaplan-Meier method to calculate all 
cause mortality. We determined the survival time for 
decedents as the period between the baseline survey 
and death; censoring was performed at three years 
for surviving participants or those lost to follow-up. 
We compared the characteristics between surviving 
and deceased participants and between those lost to 
follow-up and those successfully followed up, using 
univariate Cox models for continuous variables and 
the log rank test for categorical variables.
To examine the non-linear or irregular shape of 
the hazard functions, we used Cox models with 
penalised splines using non-parametric smoothers. We 
calculated the hazard function for the i-th participant 
in the j-th group as32: 
λj,i (t) = λj,0(t) exp (Zi(t)βz + s(Xi(t),dfi))
Where λj,0=unspecified underlying hazard function; 
βz=vector  of  parameters  for  covariate  Zi(t), and 
s(Xi(t),dfi)=penalised splines of covariates with the 
corresponding degree of freedom (df). 
With this model, we used the penalised 
partial likelihood to estimate the parameters; we 
selected penalised splines as smoothers (or spline 
functions).32-34 We performed Cox models with 
penalised splines twice. To determine whether linear 
terms or flexible spline terms should be used in further 
analyses, we examined the association of a continuous 
variable (eg, blood pressure, age, educational 
background, and body mass index) with mortality in 
the univariate Cox models with penalised splines. If 
the association between a continuous variable and 
mortality was linear, we used linear terms for that 
variable in further analyses using multivariate Cox 
models with penalised splines. If the association 
between a continuous variable and mortality was non-
linear, we used flexible spline terms for that variable 
in further analyses using multivariate Cox models with 
penalised splines.
We found the association of age (years), time spent in 
education (years), and body mass index with mortality 
to be linear (fig S2), while the associations of systolic 
blood pressure, diastolic blood pressure, mean arterial 
pressure, and pulse pressure with mortality were non-
linear (fig S3). Therefore, we used linear terms for age, 
educational background, and body mass index; we 
used flexible spline terms for systolic blood pressure, 
diastolic blood pressure, mean arterial pressure, and 
pulse pressure when performing multivariate Cox 
models with penalised splines. Based on the corrected 
Akaike information criterion, we selected the degree of 
freedom as 3 for systolic blood pressure, diastolic blood 
pressure, mean arterial pressure, and pulse pressure; 
this method had been considered as the most reliable, 
flexible criterion for fitting penalised splines in Cox 
models.35 In final Cox models with penalised splines, 
we made adjustments for: sex, age (as a linear term), 
marital status, educational background (as a linear 
term), residence, economic income, current smoking, 
current alcohol consumption, cognitive impairment, 
restriction on activities of daily living, poor visual 
function body mass index (as a linear term), central 
obesity, diabetes mellitus, cardiovascular disease, 
stroke and other cerebrovascular diseases, respiratory 
disease, cancer, and frailty.
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Cox models with penalised splines showed a 
statistically significant U shaped association for systolic 
blood pressure with three year all cause mortality. 
Participants with 129 mm Hg systolic blood pressure 
had the minimum mortality risk based on the estimated 
parameters of penalised splines after adjustment (fig 1, 
fig 2). Compared with individuals having 129 mm Hg 
systolic blood pressure, the risk of all cause mortality 
at three years was significantly higher in participants 
with systolic blood pressure lower than 107 mm Hg 
or higher than 154 mm Hg (P<0.05; fig 1, fig 2). The 
Cox models with penalised splines showed U shaped 
associations for diastolic blood pressure, mean arterial 
pressure, and pulse pressure with mortality after 
adjustment (fig 1); however, the associations were 
not statistically significant. Based on the estimated 
parameters of penalised splines after adjustment, the 
minimum mortality was around 80 mm Hg, 90 mm Hg, 
and 57.5 mm Hg for diastolic blood pressure, mean 
arterial pressure, and pulse pressure, respectively 
(fig 1).
Unlike with systolic blood pressure, we were unable 
to identify the two other points with statistically 
significant differences in all cause mortality compared 
with study participants having 80 mm Hg diastolic 
blood pressure, 90 mm Hg mean arterial pressure, and 
57.5 mm Hg pulse pressure (fig 1). Thus, in line with 
previous publications, we defined these two points (for 
classifying lower, middle, and higher groups) as 70 mm 
Hg and 90 mm Hg for diastolic blood pressure, 80 mm 
Hg and 100 mm Hg for mean arterial pressure, and 50 
mm Hg and 65 mm Hg for pulse pressure. Accordingly, 
considering blood pressure as a continuous variable, 
we stratified the participants into three categories 
(lower, middle, and higher) based on the Cox models 
with penalised splines (systolic blood pressure <107, 
107-154, and >154 mm Hg, diastolic blood pressure 
<70, 70-90, and >90 mm Hg, mean arterial pressure 
<80, 80-100, and >100 mm Hg, and pulse pressure 
<50, 50-65, and >65 mm Hg).36-38
We then used the Cox proportional hazards models 
with and without the above covariates to estimate 
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Fig 1 | Associations of blood pressure with three year all cause mortality in study population of Chinese oldest old 
people, in Cox models with penalised splines after adjustment. Lines=estimated hazard ratio of systolic blood 
pressure (129 mm Hg reference), diastolic blood pressure (80 mm Hg), mean arterial pressure (90 mm Hg), and pulse 
pressure (57.5 mm Hg) for risk of three year all cause mortality; dotted lines=95% confidence intervals; df=degrees 
of freedom 
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Fig 2 | Hazard ratio (95% CI) for three year all cause 
mortality at different levels of systolic blood pressure 
(80-190 mm Hg) in Cox models with penalised splines 
after adjustment (129 mm Hg reference), in study 
population of Chinese oldest old people
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hazard ratios and 95% confidence intervals for systolic 
blood pressure, diastolic blood pressure, mean arterial 
pressure, or pulse pressure as categorical variables. We 
also implemented Cox models with penalised splines 
to assess the associations of continuous systolic blood 
pressure with cardiovascular and non-cardiovascular 
mortality.  Adjusting  for  the  above  demographic  and 
biological covariates, we used Cox proportional 
hazards models to assess the association between 
categorical systolic blood pressure and cause specific 
mortality.
Sensitivity and subgroup analyses
To clarify the role of participants lost to follow-up in 
the associations, we did sensitivity analyses for such 
participants censored at two time points: baseline 
(0 years) and the midpoint of follow-up (1.5 years). 
To examine the possibility that excessively higher or 
lower blood pressure values could have been caused by 
acute disease resulting in increased mortality, we also 
conducted sensitivity analyses by excluding deaths in 
the first year.
Some  socioeconomic  factors,  functional  status, 
and morbidity could confound the association of 
blood pressure with mortality. Thus, we investigated 
interactions between these factors and blood pressure, 
and we conducted subgroup analyses among: 
•   Octogenarians, nonagenarians, and centenarians 
•   Urban and rural residents
•   Participants in marriage and not in marriage
•   Participants with and without comorbidities
•   Participants  with  and  without  a  self  reported 
hypertension history
•   Participants  taking  or  not  taking  anti-hypertensive 
treatment
•   Participants  with  and  without  restrictions  on 
activities of daily living
•   Robust, pre-frail, and frail participants. 
We  used  SAS  version  9.3  (SAS  Institute)  to  conduct 
statistical analyses and R version 3.4.2 (R foundation 
for Statistical Computing) to conduct Cox models with 
penalised splines.
Patient involvement
None  of  the  participants  was  involved  in  the 
questionnaire design, biological measurements, or 
outcome measures; they were likewise not involved 
in the design, recruitment, and implementation of the 
study. Furthermore, all participants or their relatives 
were informed of the systolic and diastolic blood 
pressure results and use of the data for research in this 
study. There were no plans to disseminate the study 
results to participants.
Results
Participant characteristics
The mean participant age was 92.1 years at baseline; 
57.4% (2675/4658) were female. During the follow-
up of three years, 1997 participants died and 2414 
survived (mortality rate 44.2%; table 1 and online 
supplementary materials).
Association of blood pressure with all cause 
mortality
The results of the Cox models with penalised splines 
revealed U shaped associations of systolic blood 
pressure (P<0.001), mean arterial pressure (P=0.002), 
and pulse pressure (P=0.002) with three year all cause 
mortality. We saw no significant linear (P=0.38) or 
non-linear (P=0.12) associations between diastolic 
blood pressure and mortality before adjustment. We 
identified the inflection points of the U shaped curve, 
indicating minimum mortality risk, at 143.5 mm Hg for 
systolic blood pressure, 101 mm Hg for mean arterial 
pressure, and 66 mm Hg for pulse pressure (fig S3).
However, after adjustment for confounding factors, 
the U shaped association with three year all cause 
mortality disappeared for mean arterial pressure 
(P=0.49) and pulse pressure (P=0.14), but remained 
for systolic blood pressure (P=0.035). The systolic 
blood pressure value that conferred the minimum 
mortality risk was 129 mm Hg (fig 1, fig 2). Compared 
with participants with value of 129 mm Hg, those with 
a lower (<107 mm Hg) or higher (>154 mm Hg) value 
had a higher mortality risk. Compared with 129 mm 
Hg, systolic blood pressure values of 107-154 mm 
Hg did not significantly predict higher mortality risk. 
Before the inflection point of systolic blood pressure 
at 129 mm Hg, risk of all cause mortality fell with 
increasing systolic blood pressure (hazard ratio 1.47 
(95% confidence interval 1.01 to 2.17) at 75 mm Hg, 
1.41 (1.03 to 1.93) at 80 mm Hg, 1.29 (1.06 to 1.56) 
at 90 mm Hg, 1.16 (1.03 to 1.31) at 100 mm Hg, and 
1.08 (1.01 to 1.17) at 106 mm Hg). After the inflection 
point, risk of all cause mortality rose with increasing 
systolic blood pressure (1.08 (1.01 to 1.17) at 155 mm 
Hg, 1.10 (1.01 to 1.20) at 160 mm Hg, 1.15 (1.03 to 
1.29) at 170 mm Hg, 1.21 (1.03 to 1.45) at 180 mm Hg, 
and 1.27 (1.02 to 1.58) at 190 mm Hg; fig 2).
To compare the ranges of blood pressure with 
mortality risk, we analysed Cox proportional hazards 
models with the middle range of blood pressure as the 
reference category. Compared with the middle range of 
systolic blood pressure or pulse pressure values, lower 
and higher values were significantly associated with a 
greater mortality risk after adjustment (systolic blood 
pressure: hazard ratio 1.30 (95% confidence interval 
1.11 to 1.53) for lower group, 1.16 (1.02 to 1.30) 
for higher group; pulse pressure: 1.13 (1.02 to 1.25) 
and  1.15  (1.02  to  1.29);  table  2).  After  conducting 
sensitivity analyses, the U shaped associations of 
systolic blood pressure and pulse pressure with 
mortality remained when participants lost to follow-
up were censored at 1.5 years, all participants lost to 
follow-up were removed, or participants who died in 
the first year were excluded (table 2).
Association of systolic blood pressure with all cause 
mortality in subgroups
We found significant interactions between systolic 
blood pressure and age group (octogenarians, 
nonagenarians, and centenarians, P<0.001), 
comorbidities (P=0.02), functioning in activities of 
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daily living (P<0.001), and frailty (P<0.001). We 
observed a marginally significant interaction with 
self reported hypertension history (P=0.08), and 
non-significant interactions with residence (P=0.20) 
and  marital  status  (P=0.14).  Significant  U  shaped 
associations of systolic blood pressure with three year 
all cause mortality were evident for octogenarians 
and nonagenarians but not for centenarians. For 
centenarians, we found a similar U shaped trend, but it 
was not significant (P=0.13), which could be due to the 
relatively limited study sample. We observed U shaped 
associations of systolic blood pressure with mortality 
among participants in both rural and urban areas. 
Based on the supplementary phone interview, we 
found no association between systolic blood pressure 
and mortality according to whether participants were 
taking antihypertensive treatment or not.
Association of systolic blood pressure with cause 
specific mortality
Among 1088 participants with an ascertained cause of 
death, 270 (24.8%) died from cardiovascular disease 
and 818 (75.2%) died from non-cardiovascular causes. 
Cause specific analyses showed linear associations 
between systolic blood pressure and cardiovascular 
death (P<0.001) and non-cardiovascular death 
(P<0.001; fig 3). Each increment of 10 mm Hg in 
systolic blood pressure corresponded to an 11% 
increase in cardiovascular mortality (adjusted hazard 
ratio 1.11 (95% confidence interval 1.05 to 1.18)), and 
a 5% decrease in risk of non-cardiovascular mortality 
(0.95 (0.92 to 0.99); table 3). 
Compared with middle range systolic blood pressure 
(107-154 mm Hg), higher values (>154 mm Hg) 
predicted a higher risk of cardiovascular mortality 
Table 1 | Characteristics of 4658 Chinese oldest old participants according to survival status during three year follow-
up. Data are number (%) of participants unless specified otherwise 
Characteristics Decedents (n=1997) Survivors (n=2414)* Lost to follow-up (n=247)† Total (n=4658)
Sex
 Men 833 (41.7) 1052 (43.6) 149 (60.3) 1983 (42.6)
 Women 1164 (58.3) 1362 (56.4) 98 (39.7) 2675 (57.4)
Age (year)‡ 94.7 (7.3) 89.8 (7.0), P<0.01 93.5 (8.0), P<0.01 92.1 (7.6)
Education (years)‡ 1.5 (3.0) 1.8 (3.2), P<0.01 2.9 (4.4), P<0.01 1.8 (3.2)
Marital status 
 In marriage 348 (17.4) 693 (28.7), P<0.01 52 (21.1), P<0.01 1093 (23.5)
 Not in marriage 1649 (82.6) 1721 (71.3) 195 (78.9) 3565 (76.5)
Residence 
 Urban 395 (19.8) 475 (19.7) 134 (54.3), P<0.01 1004 (21.5)
 Rural 1602 (80.2) 1939 (80.3) 113 (45.7) 3654 (78.5)
Economic income 
 High 307 (15.4) 506 (21.0), P<0.01 43 (17.4), P<0.01 856 (18.4)
 Medium or low 1690 (84.6) 1908 (79.0) 204 (82.6) 3802 (81.6)
Current smoking practice 270 (13.5) 421 (17.4), P<0.01 27 (10.9), P<0.01 718 (15.4)
Alcohol consumption habits 276 (14.0) 417 (17.3), P<0.01 36 (14.6) 731 (15.7)
Cognitive impairment 1291 (64.7) 917 (38.0), P<0.01 132 (53.4), P<0.01 2340 (50.2)
Restriction on activities of daily living 1049 (52.5) 617 (25.6), P<0.01 119 (48.2), P<0.01 1785 (38.3)
Poor visual function 782 (39.2) 573 (23.7), P<0.01 62 (25.1), P<0.01 1417 (30.4)
Frailty
 Robust 535 (26.8) 1219 (50.5), P<0.01 101 (40.9), P<0.01 1855 (39.8)
 Pre-frailty 783 (39.2) 868 (36.0) 79 (32.0) 1730 (37.1)
 Frailty 679 (34.0) 327 (13.5) 67 (27.1) 1073 (23.1)
Self reported hypertension history 478 (23.9) 662 (27.4), P<0.01 55 (22.2), P<0.01 1195 (25.7)
Body mass index‡ 19.8 (3.5) 20.9 (3.5), P<0.01 20.3 (3.6) 20.4 (3.5)
Central obesity 669 (33.5) 1037 (43.0), P<0.01 106 (43.0), P<0.01 1812 (38.9)
Diabetes mellitus 62 (3.1) 76 (3.2) 6 (2.4) 144 (3.1)
Cardiovascular disease 244 (12.2) 295 (12.2) 43 (17.4), P<0.01 582 (12.5)
Stroke and cerebrovascular disease 169 (8.5) 146 (6.1), P<0.01 33 (13.4), P<0.05 348 (7.5)
Respiratory disease 281 (14.1) 298 (12.3) 33 (13.4) 612 (13.1)
Cancer 18 (0.9) 17 (0.7) 4 (1.6) 39 (0.8)
Comorbidity
 0 1385 (69.4) 1762 (73.0), P<0.01 154 (62.4), P<0.01 3301 (70.9)
 ≥1 612 (30.6) 652 (27.0) 93 (37.6) 1357 (29.1)
Systolic blood pressure (mm Hg)‡ 134.3 (21.2) 136.0 (19.3), P<0.01 130.6 (19.2) 135.0 (20.2)
Diastolic blood pressure (mm Hg)‡ 79.2 (12.2) 79.6 (11.4) 78.4 (13.7) 79.4 (11.8)
Mean arterial pressure (mm Hg)‡ 97.6 (13.5) 98.4 (12.3), P<0.05 95.8 (14.0) 97.9 (12.9)
Pulse pressure (mm Hg)‡ 55.0 (17.3) 56.4 (16.3), P<0.01 52.2 (15.4) 55.6 (16.7)
Systolic blood pressure classification
 Lower (<107 mm Hg) 176 (8.8) 118 (4.9), P<0.01 17 (6.9) 311 (6.7)
 Middle (107-154 mm Hg) 1484 (74.3) 1888 (78.2) 201 (81.4) 3573 (76.7)
 Higher (>154 mm Hg) 337 (16.9) 408 (16.9) 29 (11.7) 774 (16.6)
Antihypertensive treatment 108 (59.3) 72 (45.9), P<0.05 — 180 (53.1)
*Survivors versus decedents.
†Participants lost to follow-up versus participants successfully followed up.
‡Data reported as the mean (standard deviation) for continuous variables.
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(adjusted hazard ratio 1.51 (95% confidence interval 
1.12 to 2.02)); lower values (<107 mm Hg) did not 
significantly predict cardiovascular mortality risk (0.91 
(0.54 to 1.56)). However, lower values predicted a 
higher risk of non-cardiovascular mortality (1.58 (1.26 
to 1.98)); higher values did not significantly predict 
non-cardiovascular mortality risk (0.97 (0.79 to 1.19); 
table 3). These results indicated that a higher systolic 
blood pressure predicted a higher risk of cardiovascular 
mortality, whereas lower values predicted a higher risk of 
non-cardiovascular mortality in the study participants.
discussion
In this community based prospective study, after 
adjustment for important identified confounders, 
systolic blood pressure presented a U shaped association 
with all cause mortality among a group of oldest old 
people  in China. Specifically, higher  values of  systolic 
blood pressure predicted a higher risk of cardiovascular 
mortality; lower values predicted a higher risk of 
non-cardiovascular  mortality.  After  we  explored  this 
association in different subgroups of participants, the 
results further supported the U shaped association 
between systolic blood pressure and mortality.
Comparison with other studies
Individuals older than 80 years have rarely been a 
target population for investigating the relations of 
blood pressure with cause specific mortality and all 
cause mortality. Previous clinical or epidemiological 
studies have reported conflicting results regarding this 
association.3-19 Most observational studies have found 
that high blood pressure predicted higher mortality 
risk,3-11 although some observational studies reported 
no relation of blood pressure with mortality.15 16
The findings of the present study has been relatively 
similar to those from previous investigations.12-14 In a 
three year follow-up of 724 participants aged 84-88 
years in Finland, participants with an systolic blood 
pressure of 140-169 mm Hg or diastolic blood pressure 
of 70-99 mm Hg had the lowest mortality risk.12  A 
study of 348 people aged 85 years and older in Sweden 
identified a U shaped association of systolic blood 
pressure with mortality; after inclusion of systolic 
blood pressure as the squared term in the adjusted Cox 
regression, the optimal value was found to be 164.2 
mm Hg for this age group.13 Among 1088 Americans 
aged 85 years and older, higher systolic blood pressure 
was found to predict improved survival during a six 
year follow-up; a J shaped association was seen after 
quadratic transformation of systolic and diastolic 
blood pressure.14 However, none of those findings of 
a J or U shaped association was based on Cox models 
with penalised splines, which were able to examine a 
non-parametric (non-linear or linear) association of 
blood pressure with mortality. 
Table 2 | Three year all cause mortality versus different levels of blood pressure, in study population of Chinese oldest old people
Variables 
and value 
groups Decedents (No)
Mortality rate  
(%; 95% CI)
Hazard ratio (95% CI) Sensitivity analyses
Unadjusted Adjusted‡
Censoring at 1.5 years 
of participants lost to  
follow-up
Removal of all  
participants lost to  
follow-up
Exclusion of  
participants who  
died in the first year
Systolic blood pressure
Lower (<107 
mm Hg)
176 58.4 (52.6 to 64.2) 1.57 (1.35 to 1.84)† 1.30 (1.11 to 1.53)† 1.27 (1.08 to 1.48)† 1.27 (1.08 to 1.48)† 1.38 (1.14 to 1.67)†
Middle (107-
154 mm Hg)
1484 42.9 (41.3 to 44.6) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Higher (>154 
mm Hg)
337 44.6 (41.0 to 48.1) 1.04 (0.93 to 1.17) 1.16 (1.02 to 1.30)* 1.15 (1.02 to 1.29)* 1.15 (1.02 to 1.29)* 1.17 (1.02 to 1.36)*
Diastolic blood pressure
Lower (<70 
mm Hg)
367 48.5 (44.9 to 52.1) 1.17 (1.04 to 1.31)* 1.02 (0.90 to 1.14) 1.04 (0.94 to 1.16) 1.07 (0.96 to 1.19) 0.99 (0.88 to 1.14)
Middle (70-
90 mm Hg)
1254 43.3 (41.5 to 45.1) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Higher (>90 
mm Hg)
376 43.7 (40.3 to 47.1) 1.02 (0.90 to 1.14) 1.01 (0.90 to 1.13) 1.02 (0.91 to 1.15) 1.03 (0.92 to 1.16) 0.96 (0.83 to 1.11)
Mean arterial pressure
Lower (<80 
mm Hg)
165 52.3 (46.5 to 58.1) 1.28 (1.08 to 1.51)† 1.08 (0.89 to 1.30) 1.13 (0.97 to 1.34) 1.13 (0.98 to 1.33) 1.13 (0.92 to 1.40)
Middle (80-
100 mm Hg)
1041 46.0 (42.4 to 49.6) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Higher (>100 
mm Hg)
791 43.9 (41.6 to 46.1) 1.02 (0.93 to 1.11) 1.08 (0.95 to 1.23) 1.07 (0.98 to 1.18) 1.09 (0.99 to 1.19) 1.08 (0.97 to 1.22)
Pulse pressure
Lower (<50 
mm Hg)
810 48.3 (45.9 to 50.7) 1.21 (1.10 to 1.34)† 1.13 (1.02 to 1.25)* 1.13 (1.02 to 1.25)* 1.14 (1.03 to 1.26)* 1.14 (1.01 to 1.29)*
Middle (50-
65 mm Hg)
731 41.5 (39.1 to 43.9) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Higher (>65 
mm Hg)
456 42.2 (39.4 to 45.3) 1.03 (0.92 to 1.16) 1.15 (1.02 to 1.29)* 1.15 (1.02 to 1.29)* 1.14 (1.01 to 1.28)* 1.15 (1.00 to 1.32)*
*P<0.05.
†P<0.01.
‡Cox proportional hazards models were applied, with adjustment for sex, age (as linear term), marital status, educational background (as linear term), residence, economic income, current 
smoking, current alcohol consumption, cognitive impairment, restriction on activities of daily living, poor visual function, body mass index (as linear term), central obesity, diabetes mellitus, 
cardiovascular disease, stroke and other cerebrovascular diseases, respiratory disease, cancer, and frailty.
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Compared with previous studies,12-14 the present 
investigation found lower levels of systolic and diastolic 
blood pressure in the oldest old study sample. This 
difference could have been due to our oversampling 
of nonagenarians and centenarians. In this survey, 
centenarians, one nearby octogenarian, and one 
nearby nonagenarian in each of the selected counties 
were interviewed. This sample was therefore different 
from a population with a naturally occurring age 
distribution, because the participants was relatively 
older (92.1 years). Accordingly, our participants could 
have had lower blood pressure because blood pressure 
declines with age after 75 years.39
The association of blood pressure with mortality 
remains unclear. In the ageing process, functional and 
organic changes in the cardiovascular system occur in 
response to metabolic alterations; those changes could 
affect blood pressure. In addition, people who survive 
to age 80 could be selected healthy individuals. It is 
possible that middle aged or younger elderly people 
with low or high blood pressure have a higher mortality 
risk; the oldest old individuals in our study could have 
been a select population3 as a result of regression to 
the mean. In our study, higher systolic blood pressure 
predicted a higher risk of cardiovascular mortality, and 
lower systolic blood pressure predicted a higher risk 
of non-cardiovascular mortality; this finding probably 
explains the U shaped association of systolic blood 
pressure with all cause mortality.
Lower blood pressure and mortality
The most likely explanation for increased mortality 
risk in participants with lower systolic blood pressure 
was chronic disease—eg, cardiovascular disease40 
(cardiac failure or ischaemic heart disease), cancer or 
other wasting diseases,41 or poor functional status or 
frailty.42 The lower values of systolic blood pressure 
observed in our participants could be due to increasing 
vascular frailty, or related to deteriorating health with 
ageing. In previous investigations of participants 
aged 85 years and older, the association of lower 
blood pressure with greater mortality disappeared 
after adjustment for poor health status.43 But in the 
present study, the association remained robust even 
after controlling for health status or functional status. 
In the subgroup analyses, the U shaped association 
persisted in participants without comorbidities, in 
those who were able to perform activities of daily 
living adequately, and in pre-frail participants. These 
findings indicated that the association of lower systolic 
blood pressure with increased mortality cannot be 
entirely explained by chronic illnesses, poor functional 
status, or frailty.
The association of lower blood pressure with greater 
mortality risk has been shown to be relevant only in 
the short term.44 As previous studies have shown,45 46 
after exclusion of death in the first year, the relation 
between lower systolic blood pressure and increased 
mortality risk remained. This finding suggested that 
lower systolic blood pressure being predictive of higher 
risks of non-cardiovascular mortality and all cause 
Systolic blood pressure (linear; P<0.001)
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Fig 3 | Associations of systolic blood pressure with three 
year cardiovascular and non-cardiovascular mortality 
risk in study population of Chinese oldest old people, 
in Cox models with penalised splines after adjustment. 
Lines=estimated hazard ratio of systolic blood pressure 
(129 mm Hg reference) for three year cardiovascular 
and non-cardiovascular mortality; dotted lines=95% 
confidence intervals 
Table 3 | Three year cause specific mortality versus different levels of systolic blood pressure, in study population of Chinese oldest old people*
Variables
Hazard ratio (95% CI)
Cardiovascular mortality Non-cardiovascular mortality All cause mortality
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Systolic blood pressure as continuous variable
Each 10 mm Hg increment 1.10 (1.04 to 1.116)‡ 1.11 (1.05 to 1.18)‡ 0.91 (0.88 to 0.94)‡ 0.95 (0.92 to 0.99)† 0.97 (0.95 to 0.99)‡ 1.01 (0.98 to 1.03)
Systolic blood pressure as categorical variable
Lower (<107 mm Hg) 0.96 (0.56 to 1.67) 0.91 (0.54 to 1.56) 1.93 (1.55 to 2.41)‡ 1.58 (1.26 to 1.98)‡ 1.57 (1.35 to 1.84)‡ 1.30 (1.11 to 1.53)‡
Middle (107-154 mm Hg) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Higher (>154 mm Hg) 1.47 (1.10 to 1.96)‡ 1.51 (1.12 to 2.02)‡ 0.84 (0.69 to 1.03) 0.97 (0.79 to 1.19) 1.04 (0.93 to 1.17) 1.16 (1.02 to 1.30)†
*Cox proportional hazards models were applied, with adjustment for sex, age (as linear term), marital status, educational background (as linear term), residence, economic income, current 
smoking, current alcohol consumption, cognitive impairment, restriction on activities of daily living, poor visual function, body mass index (as linear term), central obesity, diabetes mellitus, 
cardiovascular disease, stroke and other cerebrovascular diseases, respiratory disease, cancer, and frailty.
†P<0.05
‡P<0.01.
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mortality was more complex than a simple fall in blood 
pressure approaching death.
Higher blood pressure and mortality
The evidence for treating patients 80 years and older 
has long been debated; epidemiological studies have 
detected the association of higher blood pressure with 
increased mortality risk for this age group.2-11 In the 
present study, compared with a middle value range 
of systolic blood pressure, a higher value (>154 mm 
Hg) predicted a higher risk of all cause mortality and 
cardiovascular mortality, which was in accordance 
with other investigations.17 47-50
It has been found that treatment of hypertension 
reduced stroke while possibly increasing all cause 
mortality.47  A  study  of  3845  patients  older  than  80 
years  in  Europe,  Australasia,  Tunisia,  and  China 
showed a reduction in mortality with hypertension 
treatment.48 One large meta-analysis showed that a 
high systolic blood pressure predicted a higher risk 
of mortality for any age group, including oldest old 
people; however, the relation weakened considerably 
with ageing.17 Recent guidelines on antihypertensive 
treatment for older individuals with hypertension 
could be beneficial, including those aged over 80 
years.49 50
Associations of mean arterial pressure and pulse 
pressure with mortality
The same level of attention to systolic and diastolic 
blood pressure has not been given to pulse pressure. 
However, studies have suggested that pulse pressure 
was more sensitive for mortality predication, with 
increased aortic regurgitation or aortic stiffness 
with ageing among elderly people aged 65 years 
and older.51 52 Very few studies have focused on the 
association of mortality with pulse pressure, and those 
few studies have found no significant associations in 
oldest old people.7 The present investigation showed 
that both lower and higher pulse pressure predicted 
poor survival, suggesting that pulse pressure—and not 
just systolic and diastolic blood pressure—should be 
considered in oldest old individuals.
To our knowledge, no previous reports have focused 
on the role of mean arterial pressure in oldest old 
people—even though studies have revealed that it is 
likely to be a more accurate predictor than other blood 
pressure indexes.53 Our study showed a U shaped 
association of mean arterial pressure with mortality in 
Cox models with penalised splines before adjustment; 
however, the association was not evident on further 
analysis after adjustment.
Strengths and limitations
Our study had a large sample size to assess the role 
of blood pressure in all cause mortality and cause 
specific mortality among community based oldest 
old people in China. This large sample allowed 
robust conclusions to be drawn with respect to 
octogenarians, nonagenarians, and centenarians. This 
study performed Cox models with penalised splines to 
investigate potential non-linear associations, and our 
methodology allowed the optimal blood pressure to be 
identified. This study also focused on the association 
of mean arterial pressure with mortality among oldest 
old individuals. Furthermore, the study participation 
rate was very high (94.7%), indicating that obtaining 
death information was relatively complete.
This study had several limitations. Firstly, no 
corrections were conducted in multiple comparisons, 
which could have increased the possibility of type 1 
errors. However, the U shaped association might be a 
true association because it was consistently detected 
for systolic blood pressure and pulse pressure after 
adjustment. Secondly, blood pressure in this study was 
measured at one time only; however, the variability 
between the two blood pressure measurements at 
baseline was small. Thirdly, most of the clinical 
diseases adjusted as confounding factors were self 
reported; participants were asked whether diseases 
had been diagnosed by a doctor. Furthermore, we 
obtained information on cause specific death for only 
54% of decedents. It was difficult to determine the 
cause of death for people aged 80 years and older, 
who were likely to have various chronic diseases—
especially among those who died at home and not in 
hospital. Finally, this study included only people aged 
80 years and older; the findings cannot therefore be 
generalised to younger populations.
Conclusions
In this longitudinal, community based prospective 
study among oldest old people in China, systolic blood 
pressure showed a U shaped association with three 
year all cause mortality. This association is likely to be 
explained by the finding that higher values of systolic 
blood pressure predicted a higher risk of cardiovascular 
mortality, and lower values of systolic blood pressure 
predicted a higher risk of non-cardiovascular mortality. 
The present paradigm of “the lower the better” in 
blood pressure regulation does not apply to oldest old 
people; practitioners and researchers should be aware 
that the notion of so-called normal blood pressure 
might need to be revisited after age 80 years. Present 
guidelines for blood pressure management have been 
proposed to be applied individually and cautiously 
with  this  population.  Specific  guidelines might  need 
to be explored for blood pressure management for 
individuals older than 80 years with different blood 
pressure levels.
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